Prolongation of islet allograft survival by anti-CD45 antibody pretreatment.
Shapiro
M E
ME
Charles A. Dana Research Institute, Department of Surgery, Beth Israel Hospital, Boston, MA 02215.
Liu
M
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D002469:Cell Separation / Q000379:methods; D005260:Female; D005434:Flow Cytometry; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology; D006085:Graft Survival / Q000276:immunology*; D007515:Islets of Langerhans / Q000166:cytology; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000473:pathology; D007668:Kidney; D017493:Leukocyte Common Antigens / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D013997:Time Factors; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D017493:Leukocyte Common Antigens